Transdermal penetration of diclofenac after multiple epicutaneous administration

Journal of Rheumatology

Volumn 25, Issue 9, 1998, Pages 1833-1836

  Müller, Markus ^a   Rastelli, Christina ^b   Ferri, Paolo ^c   Jansen, Burkhard ^a   Breiteneder, Helene ^a   Eichler, Hans Georg ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Innopharma Srl

^c Poli Industria Chimica SpA   (Italy)

Author keywords

Diclofenac; Human; Microdialysis; Skin; Transdermal

Indexed keywords

DICLOFENAC;

ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG PENETRATION; DRUG TISSUE LEVEL; HUMAN; HUMAN TISSUE; NORMAL HUMAN; PERIARTHRITIS; PRIORITY JOURNAL; SKELETAL MUSCLE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; HUMANS; MALE; MICRODIALYSIS; MUSCLE, SKELETAL; SKIN ABSORPTION;

EID: 0031786554     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Grahame R. Transdermal non-steroidal anti-inflammatory agents. Br J Clin Pract 1995;49:33-5.
2. Riess W, Schmid K, Botta L, et al. Die perkutane Resorption von Diclofenac [Transdermal penetration of diclofenac]. Arzneim Forschung / Drug Res 1986;7:1092-6.
3. Radermacher J, Jentsch D, Scholl MA, Lustinetz T, Frölich JC. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol 1991;31:537-41.
4. Cross SE, Anderson C, Thompson MJ, Roberts MS. Is there tissue penetration after application of topical salicylate formulations? Lancet 1997;350:636.
5. Müller M, Mascher H, Kikuta C, et al. Diclofenac concentrations in defined tissue layers following topical administration. Clin Pharmacol Ther 1997;62:293-9.
6. Müller M, Schmid R, Georgopoulos A, Buxbaum A, Wasicek C, Eichler HG. Application of microdialysis to clinical pharmacokinetics in humans. Clin Pharmacol Ther 1995;57:371-80.
7. Lönnroth P, Jansson PA, Smith U. A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol 1987;E228-231.
8. Müller M, Schmid R, Wagner O, Osten BV, Shayganfar H, Eichler HG. In vivo characterisation of transdermal drug transport by microdialysis. J Controlled Release 1995;352:438-41.
9. Anderson C, Andersson T, Wardell K. Changes in skin circulation after insertion of a microdialysis probe visualized by laser Doppler perfusion imaging. J Invest Dermatol 1994;102:807-11.
10. Anderson C, Andersson T, Boman A, Molander M. Cutaneous microdialysis for the measurement in vivo of the percutaneous absorption of organic solvents. Curr Prob Dermatol 1996;25:37-46.
11. Assandri A, Canali S, Giachetti C. Local tolerability and pharmacokinetic profile of a new transdermal delivery system, diclofenac hydroxyethylpyrolidine plaster. Drugs Exp Clin Res 1983;19:89-95.
12. Singh P, Roberts MS. Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application. J Pharmacol Exp Ther 1994;268:144-51.
13. Davies NM, Anderson KE. Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls. Clin Pharmacokinet 1997;33: 184-213.
14. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1994;90:11693-7.
15. Wester RC, Maibach HI. Percutaneous absorption of drugs. Clin Pharmacokinet 1992;23:253-66.